Overview

Pharmacokinetic Evaluation of Testosterone Gel (1%)

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Measure and evaluate the level of testosterone in blood, and determine the safety and tolerability following daily applications of testosterone gel. Subjects who complete this trial may participate in the extension part (UMD-01-080E).
Phase:
Phase 1
Details
Lead Sponsor:
Solvay Pharmaceuticals
Collaborator:
Unimed Pharmaceuticals
Treatments:
Methyltestosterone
Testosterone
Testosterone 17 beta-cypionate
Testosterone enanthate
Testosterone undecanoate